Aşırı Duyarlılık Reaksiyonları ve Kanıta Dayalı Tedavi Bakım Uygulamaları

Ateş K. ve ark. Türk Nefroloji ve Transplantasyon Registry 2022 Raporu, Ankara.

Warrington R, Watson W, Kim HL, Antonetti FR. An introduction to immunology and immunopathology. Allergy Asthma Clinical Immunology, 2011; Nov 10;7 Suppl 1(Suppl 1), 2-8. doi: 10.1186/1710-1492-7-S1-S1.

Kalkan G. Tip 1 Alerjik Reaksiyonların Klinik Görünümleri. Journal of Contemporary Medicine, 2020;10(2):290-294. doi 10.16899/jcm.578634.

Saha M, Allon M: Diagnosis, Treatment, and Prevention of Hemodialysis Emergencies. Clinical Journal American Society of Nephrology, 2017;12:357–369. Doi: 10.2215/CJN.05260516

Solensky R, Khan DA, Bernstein IL, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunology, 2010; 105: 259-73.

Demoly P, Adkinson NF, Brockow K, et al. International consensus on drug allergy. Allergy, 2014; 69: 420-37.

Alvarez-de Lara MA, Martin A. Hypersensitivity reactions to synthetic haemodialysis membranes — an emerging issue? Nefrologia, 2014;34(6):698-702. doi:10.3265/Nefrologia.pre2014.Jul.12682

Demoly P, Adkinson NF, Brockow K, et al. International consensus on drug allergy. Allergy, 2014; 69: 420-37.

Sayeed K, Murdakes C, Spec A, Gashti C. Anaphylactic shock at the beginning of hemodialysis. Dialysis Rounds, 2016; 29 (2) : 81–84.

Hempel JC, Poppelaars F, Gaya da Costa M, et al. Distinct in vitro complement activation by various intravenous iron preparations. American Journal of Nephrology, 2017;45: 49e59

Fishbane S. Safety İn İron Management. American Journal of Kidney Disease, 2003;41:18-26

Gaudy-Marqueste, Jouhet C, Castelain M, et al. Contact allergies in haemodialysis patients: a prospective study of 75 patients. Allerge, 2009;64:222-228.

Simon P, Potier J, Thebaud HE. Risk factors for acute hypersensitivity reactions in hemodialysis. Nephrologie, 1996;17: 163-70.

Bouré T, Vanholder R. Which dialyser membrane to choose? Nephrology Dialysis Transplantation, 2004: 19: 293–296. doi.org/10.1093/ndt/gfg508

Butani L, Calogiuri G. Hypersensitivity reactions in patients receiving hemodialysis. Ann Allergy Asthma Immunology, 2017; 118: 680-684

Heegard KD, Tilley MA, Stewart IJ, Edgecombe HP, Lundy JB, Renz EM, Chung KK. Anaphylactoid reaction during first hemofiltration with a PUREMA® polysulfone membrane. International Journal of Artif Organs, 2013; 36 : 363–366.

Beaudouin E, Kanny G, Morisset M, Renaudin JM, Mertes M, Laxenaire MC et al. Immediate hypersensitivity to chlorhexidine: literature review. Allergy Immunol. 2004;36:123–126

Le Pabic F, Sainte-Laudy J, Blanchard N, Moneret-Vautrin DA. First case of anaphylaxis to iodinated povidone. Allergy, 2003; 58:826–827.

Adachi A, Fukunaga A, Hayashi K, Kunisada M, Horikawa T. Anaphylaxis to polyvinylpyrrolidone after vaginal application of povidone-iodine. Contact Dermatitis, 2003; 48:133–136. doi: 10.1034/j.1600-0536.2003.00050.x.

Sánchez-Villanueva RJ, González E, Quirce S, Díaz R, Álvarez L, Menéndez D et al. Reacciones de hipersensibilidad a membranas sintéticas de hemodiálisis. Nefrologia; 2014;34(4):520-5.

Marques ID, Pinheiro KF, de Freitas do Carmo LP, Costa MC, Abensur H. Anaphylactic reaction induced by a polysulfone/polyvinylpyrrolidone membrane in the 10th session of hemodialysis with the same dialyzer. Hemodialysis International, 2011; 15(3):399-403.

Estreas et al. Incidence of Hypersensitivity Reactions During Hemodialysis. Kidney and Blood Pressure Research, 2018;43(5):1472-1478. doi: 10.1159/000493662.

Verresen L, Fink E, Lemke HD, Van Renterghem Y: Bradykinin is mediatör of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney International,1994; 45: 1497–1503

Schulman G, Hakim R, Arias R, Silverberg M, Kaplan AP, Arbeit L: Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. Journal of the American Society of Nephrology, 19933: 1563–1569.

Coppo R, Amore A, Cirina P, Scelfo B, Giacchino F, Comune L et al. Bradykinin and nitric oxide generation by dialysis membranes can be blunted by alkaline rinsing solutions. Kidney International, 2000; 58:881–888.

Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostino A et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. Journal of Pharmacology and Experimental Therapeutics, 2002;303:232–237. doi: 10.1124/jpet.102.038067.

De´sormeaux A, Moreau ME, Lepage Y, et al. The Effect Of Electronegativity And Angiotensin-Converting Enzyme İnhibition On The Kinin-Forming Capacity Of Polyacrylonitrile Dialysis Membranes. Biomaterials, 2008; 29: 1139-1146. DOI: 10.1016/j.biomaterials.2007.11.019

Maheut H, Lacour F. AN69 ST membrane: a dialysis centre experience. Nephrology Dialysis Transplantation, 2001; 16:1519-20.

Krieter DH, Fink E, Bonner G, You HM, Eisenhauer T. Anaphylactoid reactions during haemodialysis in sheep are associated with bradykinin release. Nephrology Dialysis Transplantation, 1995;10:509-513.

González Sanchidrián S, Labrador Gómez PJ, Marín Álvarez JP, et al. Reacción a membranas sintéticas en hemodiálisis. Nefrología, 2016;36:707–709.

Martín-Navarro JA, Gutiérrez-Sánchez MJ, Petkov-Stoyanov V. Hipersensibilidad a membranas sintéticas de hemodiálisis. Nefrologia, 2014; 34(6):807-8.

Rodríguez-Sanz A, Sánchez-Villanueva R, Domínguez-Ortega J, et al. Mechanisms Involved in Hypersensitivity Reactions to Polysulfone Hemodialysis Membranes. Artif Organs, 2017; 41(11):285-295. doi: 10.1111/aor.12954.

Ohashi N, Yonemura K, Goto T, Suzuki H, Fujigaki Y, Yamamoto T, et al. A case of anaphylactoid shock induced by the BS polysulfone hemodialyzer but not by the F8-HPS polysulfone hemodialyzer. Nephrology, 2003; 60:214-7.

Ebo DG, Bosmans JL, Couttenye MM, Stevens WJ: Haemodialysis-associated anaphylactic and anaphylactoid reactions. Allergy, 2006; 61:211–220.

Rodriguez-Sanz A, Sánchez-Villanueva R, Domínguez-Ortega J, et al. Characterization of hypersensitivity reactions to polysulfone hemodialysis membranes. Annals of Allergy, Asthma & Immunology, 2022; 128(6): 713-720.

Greinacher A. CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia. Heparin-Induced Thrombocytopenia. The New England Journal of Medicine, 2015; 373 : 252–261. Doi: 10.1056/NEJMcp1411910.

Warkentin TE, Greinacher A. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opinion on Drug Safety, 2009; 8:129–144.

Sagedal S. Hartmann A. Low molecular weight heparins as thromboprophylaxis in patients undergoing hemodialysis/hemofiltration or continuous renal replacement therapies. European Journal of Medical Research, 2004; 30;9(3):125-30.

Figarella I, Barbaud A, Lecompte T, et al. Cutaneous delayed hypersensitivity reactions to heparins and heparinoids. Anneles de Dermatologie Venereologie, 2001 ; 128 : 25-30.

Canaud B, Aljama P, Tielemans C, et al. Pathochemical toxicity of perfluotocarbon-5070, a liquid test performance fluid previously used in dialyzer manufacturing, confirmed in animal experiment. Journal of the American Society of Nephrology, 2005;16:1819-2.

Rampton D, Folkersen J, Balıkboğan S, et al. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica, 2014; 99 : 1671–1676. doi: 10.3324/haematol.2014.111492.

Ebo DG. Haine SE, Hagendorens MM, et al. Hypersensitivity to nadroparin calcium : case report and review of the literatüre. Clinical Drug Investigation, 2004;24(7):421-6. doi: 10.2165/00044011-200424070-00005.

Berkun Y, Aviv YS, Schwartz LB, Shalit M. Heparin-induced recurrent anaphylaxis. Clinical Experimental& Allergy, 2004;34(12):1916-8.

Michael B, Coyne DW, Fishbane S, et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney International, 2002; 61(5):1830-9. doi: 10.1046/j.1523-1755.2002.00314.x.

Ingelmo AR, Dıaz ID, Moreno RC, et al. Torres Jaén MJClinical Practice Guidelines for Diagnosis and Management of Hypersensitivity Reactions to Contrast Media. Journal Of Investig Allergology and Clinical Immunology, 2016; 26 (3):144-55. doi: 10.18176/jiaci.0058

Hoffman HJ, Santos AF, Mayorga J, et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy: 2015; 70(11):1393-405. doi: 10.1111/all.12698. Epub 2015 Sep 8

Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis-a practice parameter update. Annals of Allergy, Asthma & Immunology, 2015;115:341-384

Aljadi Z, Mansouri L, Nopp A, et al. Activation of basophils is a new and sensitive marker of biocompatibility in hemodialysis. Artif Organs. 2014;38: 945-953. DOI: 10.1111/aor.12297

Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter. Journal of Allergy Clinical Immunology, 2010;126:477-80.

Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. National England Journal of Medicine, 2008;358:28-35

Stone SF, Cotterell C, Isbister GK, Holdgate A, Brown SG. Emergency Department Anaphylaxis Investigators. Elevated serum cytokines during human anaphylaxis: identification of potential mediators of acute allergic reactions. J Allergy Clin Immunol 2009;124:786-92.

Ono E, Taniguchi M, Mita H, et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clinical Experiment & Allergy, 2009;39:72-80.

Orhan F, Civelek E, Şahiner ÜM. Anafilaksi Ulusal Rehberi 2018. Astım, Allerji, İmmünoloji. 2018. 6 (1): 1-68.

Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy, 2003;58:854-63

Kroigaard M, Garvey LH, Gillberg L, et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anesthesia. Acta Anaesthesiol Scandınavıca, 2007;51:655-70.

Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. Journal of Allergy Clinical Immunology, 2005; 115(3):S483–523. DOI: 10.1016/j.jaci.2005.01.010

Ellis AK, Day JH. Diagnosis and management of anaphylaxis. CMAJ, 2003;169:307–311.

Badui I, Diena D, Guida G, et al. Cutaneous allergic reaction correlates with anti‐erythropoietin antibodies in dialysis patient developing pure red cell aplasia. Clinical Case Report, 2022; 10(4): 1-4. doi: 10.1002/ccr3.5554

Cronin RE, Reilly RF. Unfractionated Heparin for Hemodialysis: Still the Best Option. Seminars in Dialysis, 2010; 23(5): 510–515.

Simons FE, Ardusso LR, Bilo MB, et al. International consensus on (ICON) anaphylaxis. World Allergy Organization Journal, 2014;7(9): 2-19. DOI: 10.1186/1939-4551-7-9

Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. Journal of Allergy Clinical Immunology, 2004;113:837–844

Sampson HA. Anaphylaxis and emergency treatment. Pediatrics, 2003; 111:1601–1608.

Simons FE, X Gu, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection Journal of Allergy Clinical Immunology, 2011; 108 . 871-873.

Misaki T, Suzuki Y, Naito Y, Shiooka T. A case of anaphylactoid to acetate in acetate-containing bicarbonate dialysate. CEN Case Rep (2015) 4:81–84 DOI 10.1007/s13730-014-0144

Inoshita H, Ohsawa I, Onda K, et al. An analysis of functional activity via the three complement pathways during hemodialysis sessions: a new insight into the association between the lectin pathway and C5 activation. Clinical Kidney Journal, 2012;5:401-404

Hanada K, Shirai S, Shibagaki Y, Kimura K. A case of hemodialysis-associated anaphylaxis or anaphylactoid reaction, which responded successfully to very gradual tapering dose of corticosteroid. Therapeutic Apheresis and Dialysis, 2011; 15:506-507. https://doi.org/10.1111/j.1744-9987.2011.00977

Macdougall IC et al. Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Kidney International, 2016; 89(1):28-39. doi: 10.1016/j.kint.2015.10.002.

Cançado RD, Muñoz M. Intravenous iron therapy: how far have we come? Revista brasileira de hematologia e Hemoterapia, 2011; 33 : 461–469.

Auerbach M, Macdougall IC . Safety of intravenous iron formulations: facts and folklore. Blood Transfus, 2014 ; 12(3): 296–300.doi: 10.2450/2014.0094-14

Barton JC, Barton EH, Bertoli LF, Gothard CH, Sherrer JS. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation. American Journal of Medicine,2000; 109 : 27–32

Wang C, Graham DJ, Kane RC, et al. Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products. JAMA, 2015;314(19):2062-2068. doi:10.1001/jama.2015.15572